OPTIMUM study protocol: an adaptive randomised controlled trial of a mixed whole-cell/acellular pertussis vaccine schedule
Introduction Combination vaccines containing whole-cell pertussis antigens were phased out from the Australian national immunisation programme between 1997 and 1999 and replaced by the less reactogenic acellular pertussis (aP) antigens. In a large case–control study of Australian children born durin...
Main Authors: | Gladymar Perez Chacon, Marie J Estcourt, Patrick G Holt |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2020-12-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/10/12/e042838.full |
Similar Items
-
Acellular versus Whole-Cell Pertussis Vaccines
by: S Halperin, et al.
Published: (1992-01-01) -
Proteomics of Bordetella pertussis whole-cell and acellular vaccines
by: Jens Möller, et al.
Published: (2019-06-01) -
Comparative analysis of whole-cell and acellular pertussis vaccines efficacy in preventing pertussis
by: I. A. Alekseeva, et al.
Published: (2018-02-01) -
Pertussis vaccination of African infants using acellular and whole-cell vaccines.
by: Ramkissoon, Arthi.
Published: (2012) -
Is it time to administer acellular pertussis vaccine to childbearing age/pregnant women in all areas using whole-cell pertussis vaccination schedule?
by: Abdoulreza Esteghamati, et al.
Published: (2021-05-01)